Wells Fargo
NVO

Wells Fargo’s Novo Nordisk NVO Stock Holding History

Wells Fargo’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,600
Closed -$10K – 7223
2020
Q4 		$10K Hold
42,600
– – ﹤0.01% 6023
2020
Q3 		$27K Buy
+42,600
New +$1.42M ﹤0.01% 5684
2019
Q4 		– Sell
-139,400
Closed -$28K – 6618
2019
Q3 		$28K Buy
+139,400
New +$3.52M ﹤0.01% 5729

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Wells Fargo's NVO Position: Q1 2026 in Review

Wells Fargo reduced its Novo Nordisk (NVO) stake by 8.8% in Q1 2026, selling an estimated $16.6M and leaving 3,642,599 shares worth $134M. The position accounts for 0.03% of the portfolio, ranked #525.

Wells Fargo first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $583M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Wells Fargo held 3,642,599 shares of Novo Nordisk worth $134M as of Q1 2026.
  • Wells Fargo sold 349,450 Novo Nordisk shares in Q1 2026, an estimated $16.6M.
  • Novo Nordisk made up 0.03% of Wells Fargo's portfolio in Q1 2026, its #525 holding.
  • Wells Fargo first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Novo Nordisk position peaked at $583M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.